1. Home
  2. WH vs CORT Comparison

WH vs CORT Comparison

Compare WH & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WH
  • CORT
  • Stock Information
  • Founded
  • WH 2017
  • CORT 1998
  • Country
  • WH United States
  • CORT United States
  • Employees
  • WH N/A
  • CORT N/A
  • Industry
  • WH Hotels/Resorts
  • CORT Biotechnology: Pharmaceutical Preparations
  • Sector
  • WH Consumer Discretionary
  • CORT Health Care
  • Exchange
  • WH Nasdaq
  • CORT Nasdaq
  • Market Cap
  • WH 6.8B
  • CORT 7.5B
  • IPO Year
  • WH N/A
  • CORT N/A
  • Fundamental
  • Price
  • WH $83.99
  • CORT $72.30
  • Analyst Decision
  • WH Strong Buy
  • CORT Strong Buy
  • Analyst Count
  • WH 11
  • CORT 4
  • Target Price
  • WH $105.16
  • CORT $138.25
  • AVG Volume (30 Days)
  • WH 1.3M
  • CORT 886.1K
  • Earning Date
  • WH 07-23-2025
  • CORT 07-31-2025
  • Dividend Yield
  • WH 1.96%
  • CORT N/A
  • EPS Growth
  • WH 38.05
  • CORT N/A
  • EPS
  • WH 4.27
  • CORT 1.11
  • Revenue
  • WH $1,448,000,000.00
  • CORT $716,080,000.00
  • Revenue This Year
  • WH $7.91
  • CORT $35.85
  • Revenue Next Year
  • WH $6.07
  • CORT $35.22
  • P/E Ratio
  • WH $19.67
  • CORT $64.87
  • Revenue Growth
  • WH 4.32
  • CORT 25.71
  • 52 Week Low
  • WH $72.14
  • CORT $33.34
  • 52 Week High
  • WH $113.07
  • CORT $117.33
  • Technical
  • Relative Strength Index (RSI)
  • WH 44.17
  • CORT 55.16
  • Support Level
  • WH $83.23
  • CORT $69.14
  • Resistance Level
  • WH $86.84
  • CORT $71.91
  • Average True Range (ATR)
  • WH 2.50
  • CORT 2.62
  • MACD
  • WH -0.67
  • CORT 0.40
  • Stochastic Oscillator
  • WH 14.24
  • CORT 92.70

About WH Wyndham Hotels & Resorts Inc.

As of Dec. 31, 2024, Wyndham Hotels & Resorts operates 903,000 rooms across more than 20 brands predominantly in the economy and midscale segments. Super 8 is the largest brand, representing around 18% of all rooms, with Days Inn (13%) and Ramada (14%) the next two largest brands. During the past several years, the company has expanded its extended stay/lifestyle brands, which appeal to travelers seeking to experience the local culture of a given location. The company closed its La Quinta acquisition in the second quarter of 2018, adding around 90,000 rooms at the time the deal closed. Wyndham launched a new extended stay economy scale segment concept, ECHO, in the spring of 2022. The United States represents 56% of total rooms.

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.

Share on Social Networks: